<i>Post-hoc</i> analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis
<i>Post-hoc</i> analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does <i>Post-hoc</i> analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis have?
<i>Post-hoc</i> analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis has 17 citations in the OpenAlex counts ScholarIQ stores.
When was <i>Post-hoc</i> analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis published?
<i>Post-hoc</i> analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis has 2019 year in the ScholarIQ index.
What is the open-access status of <i>Post-hoc</i> analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis?
<i>Post-hoc</i> analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis has hybrid oa status in the ScholarIQ index.
What is the DOI of <i>Post-hoc</i> analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis?
The DOI for <i>Post-hoc</i> analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis is on the source record.
What is the PMID of <i>Post-hoc</i> analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis?
The PMID for <i>Post-hoc</i> analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis is on the source record.
What is the OpenAlex record for <i>Post-hoc</i> analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis?
The OpenAlex for <i>Post-hoc</i> analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis is on the source record.